Clinical Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A Randomized, Subjects and Investigator Blinded, Placebo Controlled Parallel Group Study to Assess the Mode of Action of QBW251 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Novartis Pharmaceuticals
Terminated
Sponsor decision
Other terminated trials from Novartis Pharmaceuticals
Other Chronic Obstructive Pulmonary Disease trials with similar outcome
This PHASE2 trial investigates Chronic Obstructive Pulmonary Disease and is currently terminated or withdrawn. Novartis Pharmaceuticals leads this study, which shows 21 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
21 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Nov 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Completed → Terminated
-
Jun 2023 — Nov 2023 [monthly]
Completed PHASE2
▶ Show 16 earlier versions
-
Nov 2022 — Jun 2023 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Sep 2022 — Nov 2022 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Apr 2022 — Sep 2022 [monthly]
Recruiting PHASE2
-
Mar 2022 — Apr 2022 [monthly]
Recruiting PHASE2
-
Jan 2022 — Mar 2022 [monthly]
Recruiting PHASE2
-
Dec 2021 — Jan 2022 [monthly]
Recruiting PHASE2
-
Nov 2021 — Dec 2021 [monthly]
Recruiting PHASE2
-
Oct 2021 — Nov 2021 [monthly]
Recruiting PHASE2
-
Apr 2021 — Oct 2021 [monthly]
Recruiting PHASE2
-
Feb 2021 — Apr 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE2
-
Sep 2020 — Oct 2020 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2020 — May 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Novartis Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Basel, Switzerland , Berlin, Germany , Bradford, United Kingdom , Feldbach, Austria , Frankfurt, Germany , Heidelberg, Germany , London, United Kingdom , Mainz, Germany , Sankt Gallen, Switzerland , Witten, Germany and 1 more location